Back

Beyond the change: exploring age of menopause, lifestyle, and cardiovascular risk in women

31 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women (3) Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Anushriya Pant

Sydney (Australia)

7 More presentations in this session

Presentation thumbnail
Sex disparities in bystander defibrillation for out-of-hospital cardiac arrest
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Sex-specific associations between remnant cholesterol and cardiovascular risk in patients undergoing percutaneous coronary intervention: a 5-year large-sample study from the real world
Doctor K. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term prognosis and predictors of death in chronic Chagas cardiomyopathy in women and men.
Professor A. Mansur (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Novel deep learning algorithm demonstrates strong performance for detection and quantification of breast arterial calcification and associates with cardiovascular disease
Doctor V. Goel (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of sex and age on culprit plaque type of acute coronary syndrome in Japanese patients from TACTICS registry
Doctor T. Shinke (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular disease in women (3)

The Event

Event poster

ESC Congress 2024

31 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Menopause timing and cardiovascular health: an individual participant data and literature-based meta-analysis of 13 studies and 22,249 postmenopausal women
thumbnail
Congress Presentation
Assessment of cardiovascular risk in peri- and postmenopausal women: preliminary results for the development of a better risk assessment tool
thumbnail
Congress Presentation
Earlier menopause is related to adverse left ventricular morphology and function in the UK Biobank

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources